Publication/Presentation Date

2-1-2020

Abstract

The treatment of metastatic melanomas revolutionized during the past decade because of a better understanding of various pathways and mutations that play different roles in the pathogenesis of this disease. The incorporation of immunotherapy was the first in these efforts, followed by targeted therapies as monotherapeutic options, and then in combinations. In this article, we review the historical and landmark clinical trials that changed our treatment paradigm for advanced melanomas, also we review ongoing clinical trials that would be applicable in the near future and would expectedly improve outcomes for these patients.

Volume

100

Issue

1

First Page

201

Last Page

208

ISSN

1558-3171

Disciplines

Medicine and Health Sciences | Oncology

PubMedID

31753113

Peer Reviewed for front end display

Peer-Reviewed

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Hematology-Medical Oncology Division Fellows and Residents, Department of Medicine Faculty, Department of Medicine Fellows and Residents

Document Type

Article

Included in

Oncology Commons

Share

COinS